✦ LIBER ✦

Genentech's glyco-engineered antibody to succeed Rituxan

✍ Scribed by Ratner, Mark

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Alfimeprase to succeed Genentech's altep

✍ Vastag, Brian 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 300 KB

Erratum: Alfimeprase to succeed Genentec

✍ Vastag, Brian 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 53 KB

Genentech's Alzheimer's antibody trial t

✍ Garber, Ken 📂 Article 📅 2012 🏛 Nature Publishing Group 🌐 English ⚖ 175 KB

An engineered human antibody to TNF (CDP

✍ William J. Sandborn; Brian G. Feagan; Stephen B. Hanauer; Daniel H. Present; Llo 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 160 KB

Bexxar (Tositumomab) Protocol CP98-020:

✍ Akins, R.S.; Nair, M.; Mark, R.J.; Anderson, P.J.; Quick, D. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 42 KB